NovoCure (NVCR) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Finance · 1 week ago
Open | 16.22 |
High | 16.59 |
Low | 16.02 |
Mkt Cap | 1.77B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 16.13 |
52 Wk. Low | 10.87 |
52 Wk. High | 83.60 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 138.5M | 13.40% ▲ |
Net Income | -38.76M | - |
Diluted EPS | -0.36 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | -$0.41 | - |
Q1 2024 | -$0.42 | -$0.36 |
Q4 2023 | -$0.52 | -$0.45 |
S&P 500^GSPC | 5,222.68+94.89 (+1.85%) |
Dow 30^DJI | 39,512.84+125.04 (+0.32%) |
Nasdaq^IXIC | 16,340.87+184.57 (+1.14%) |
214.93-0.45% | |
73.79-1.06% | |
78.14-0.14% |